Ruth Tal-Singer is Joining the COPD Foundation Team
WASHINGTON, DC, October 25, 2019— The COPD Foundation is pleased to announce that Ruth Tal-Singer, Ph.D., has joined the Foundation as a consultant in the role of Scientific Strategy Advisor. Ms. Tal-Singer is an internationally recognized expert and leader in the field of respiratory care. Her appointment became official as of October 21, 2019.
"We are so very excited that Ruth is joining the team. Ruth's deep expertise and commitment to the COPD community is so very impactful,” said Corinne Costa Davis, Chief Executive Officer of the COPD Foundation.
Prior to joining the COPD Foundation, Ms. Tal-Singer was Vice President of Medical Innovation (Galaxy) R&D Value Evidence & Outcomes and Senior Fellow at GSK Pharmaceuticals. During her career with GSK, she led many projects that resulted in new and innovative treatments for COPD.
“We are all thrilled that Ruth Tal-Singer will be joining the COPD Foundation. Ruth brings a vast experience in COPD research and development. Beyond her scientific expertise she has a deep commitment to the mission of the COPD Foundation- to prevent and cure chronic obstructive pulmonary disease (COPD) and to improve the lives of all people affected by COPD. Her recruitment represents a major step forward for the Foundation,” said Dr. Byron Thomashow, Chief Medical Officer at the COPD Foundation.
Ruth has served as Industry Chair of our COPD Biomarker Qualification Consortium, which achieved global regulatory qualification of drug development tools that are imperative for the development of therapies for COPD. Her vast knowledge and experience will be of great benefit to the COPD Foundation as we continue our efforts to find new ways to treat this disease.
COPD encompasses progressive lung diseases such as emphysema, chronic bronchitis, refractory asthma and severe bronchiectasis. The disease is characterized by increasing breathlessness.
About the COPD Foundation
The COPD Foundation’s mission is to prevent and cure chronic obstructive pulmonary disease and improve the lives of all people affected by COPD. The Foundation’s activities focus on achieving these results through research, education and advocacy programs. To learn more about the COPD Foundation, please visit www.copdfoundation.org.
The COPD Foundation
Bret Denning, Care Delivery & Communications Program Specialist
1-866-731-2673 ext. 201